Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Songbird Hearing was a pioneering medical device company that developed and commercialized the world's first disposable hearing aid. Founded in 1997 as a spin-off from Sarnoff Corporation (formerly RCA Labs), the company aimed to provide affordable and convenient hearing solutions for the millions of adults with mild-to-moderate hearing loss. Its flagship products, including the Songbird Disposable and Songbird Ultra, utilized digital signal processing and were sold through retail channels like CVS and Walgreens. Despite significant backing from major investors like Johnson & Johnson and Procter & Gamble, the company struggled with market adoption and financial sustainability, leading to its eventual closure and the sale of its brand assets in 2012.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Songbird Hearing.